key: cord-0074789-m9oorke2
authors: Godsland, Jane; Lau, Esther; Davis, Sophia
title: Thank you to our peer reviewers
date: 2022-02-16
journal: Lancet Child Adolesc Health
DOI: 10.1016/s2352-4642(22)00038-4
sha: 945cfb8bad9dc3e74a885554c5283e12a20c17f8
doc_id: 74789
cord_uid: m9oorke2

nan

2021 saw our colleagues in child and adolescent health again operate under challenging circumstances. The focus remained on the COVID-19 pandemic, with efforts centred on understanding the evolving SARS-CoV-2 virus and the emerging MIS-C disease, and the efficacy, palatability, and politicisation of vaccinations for young people. Simultaneously, we strove to understand the broader effects of the pandemic, and the interruptions and constraints on the lives of billions of young people worldwide. Meanwhile, pressing pre-existing challenges for global child and adolescent health remained, such as the double burden of malnutrition and obesity, persistent under-5 mortality and global health inequities, and devastating chronic diseases and mental illness.

Despite ongoing restrictions and redirected priorities, we continued to publish the most impactful research and influential opinion across all areas of child and adolescent health and wellbeing. We could not do this without the contributions from of our wonderful peer reviewers. They are the unsung heroes of scientific discourse and rigour, and we are extremely grateful to all those who made time to share their expertise with us and our authors in 2021. A full list of all our reviewers is available in this issue.

The Lancet Child & Adolescent Health is mindful of the value of diversity among reviewers. In 2021, 46% of our clinical reviewers self-reported as women, 52% as men, 1% as non-binary, and 2% did not say. 48% of our statistical reviewers self-reported as women and 52% as men. As a global journal, it is essential to reflect the internationality of our content and the populations studied, so we always seek a peer reviewer from the country in which a study is done. 85% of our reviewers were from high-income countries, and 15% from lowincome and middle-income countries (LMICs). 2021 also saw the launch of our Youth Advisory Board to ensure we advocate for "nothing about us without us". Working with our eight members continues to be a valuable and rewarding endeavour, and we look forward to sharing more of their contributions during 2022.

Our journal remains committed to gender equity in research. In December, 2019, 1 we declared our aim to see women constitute 75% of all our authors, to reflect the gender distribution of the paediatric workforce. In 2021, only 39% of the corresponding authors for our research papers were women (vs 45% in 2019). Although disappointing, self-reported gender data are only available for corresponding authors, so the proportion of women across all authors could be higher. A reduction in the proportion of female authors in 2021 is unsurprising; women shouldered more caring responsibilities during the pandemic than men, and the higher proportion of infectious disease papers in our journal this year might have affected gender distribution of authors. More encouragingly, 54% of corresponding authors of our commissioned pieces self-reported as women (vs 47% in 2019) and 11% of our commissioned authors were women from LMICs (vs 3·5% in 2019, surpassing our 10% target). These successes reflect our efforts to engage writers that reflect the diversity of our content.

In the year ahead, we will continue towards our goal of appropriately representing the diversity of the paediatric workforce, and we will continue to diversify our author and reviewer pools to include experts of all genders, geographies, career stages, abilities, and ages.

The Lancet Child & Adolescent Health, London EC2Y 5AS, UK

Challenges in tracking global malaria spending

Addressing budget reduction and reallocation on health-related resources during COVID-19 pandemic in malaria-endemic countries

Annual SMC reports from SMC implementing countries. SMC Alliance 2020 Annual meeting

Health financing in sub-Saharan Africa: from analytical frameworks to empirical evaluation

Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis